Insamo
Berkeley · Founded 2022
About Insamo
Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides which lies in its automated process of designing, synthesizing, and testing at an unprecedented scale.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.0M
- Funding stage: Seed
- Last round: Non-Equity Assistance (Apr 2024)
- Website: https://insamo.com/
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/insamo-89922 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.